Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 184 Records) |
| Query Trace: Disease and IDH1[original query] |
|---|
| Persistent IDH mutations are not associated with increased relapse or death in patients with IDH -mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. medRxiv : the preprint server for health sciences 2023 9 . Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambind |
| IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience. BMC cancer 2023 9 23 (1): 907. Elisabetta Setola, S Benini, A Righi, G Gamberi, E Carretta, C Ferrari, S Avnet, E Palmerini, G Magagnoli, M Gambarotti, P L Lollini, M Cesari, S Cocchi, A Paioli, A Longhi, K Scotlandi, M A Laginestra, D M Donati, N Baldini, T Ibrah |
| Clinico-genomic profiling of conventional and dedifferentiated chondrosarcomas reveals TP53 mutation to be associated with worse outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Ryan A Denu, Richard K Yang, Alexander J Lazar, Shalin S Patel, Valerae O Lewis, Jason Roszik, J Andrew Livingston, Wei-Lien Wang, Kenna R Shaw, Ravin Ratan, Maria A Zarzour, Justin Bird, Shaan M Raza, Kadir C Akdemir, Jordi Rodon Ahnert, Vivek Subbiah, Shreyaskumar Patel, Anthony P Conl |
| Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro-oncology 2023 9 . Steven Tobochnik, Maria Kristina C Dorotan, Hia S Ghosh, Emily Lapinskas, Jayne Vogelzang, David A Reardon, Keith L Ligon, Wenya Linda Bi, Stelios M Smirnakis, Jong Woo L |
| Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. medRxiv : the preprint server for health sciences 2023 8 . Gege Gui, Laura W Dillon, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery Auletta, Firas El Chaer, Evan Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Stephen R Spellman, Scott L Zeger, Kristin M Page, Christopher S Hourig |
| Platinum Sensitivity in IDH1/2 mutated Intrahepatic Cholangiocarcinoma: Not all "BRCAness" is Created Equal. Cancer investigation 2023 7 1-11. Deborah Blythe Doroshow, Wei Wei, Meenakshi Mehrotra, Daniella Sia, Joseph Paul Eder, Ranjit Bindra, Jane Houldsworth, Patricia LoRusso, Zenta Walth |
| Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience. Therapeutic advances in medical oncology 2023 7 15 17588359231171574. Margherita Rimini, Valentina Burgio, Lorenzo Antonuzzo, Lorenza Rimassa, Ester Oneda, Caterina Soldà, Pasqua Cito, Guglielmo Nasti, Daniele Lavacchi, Valentina Zanuso, Mario Domenico Rizzato, Alberto Zaniboni, Alessandro Ottaiano, Mara Persano, Noemi Cornara, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardi |
| Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood advances 2023 5 . Melanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, James S Blachly, Shelley Orwick, Karilyn Larkin, Christopher C Oakes, Andrew Hantel, Andrew J Carroll, William Blum, Bayard L Powell, Geoffrey L Uy, Richard M Stone, Richard A Larson, John C Byrd, Electra D Paskett, Jesse J Plascak, Ann-Kathrin Eisfe |
| Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis. Cancer immunology, immunotherapy : CII 2023 10 . Jiashuo Chao, Shanshan Wang, Hao Wang, Nan Zhang, Yunchao Wang, Xu Yang, Chengpei Zhu, Cong Ning, Xinmu Zhang, Jingnan Xue, Longhao Zhang, Mingjian Piao, Mingming Wang, Xiaobo Yang, Ling Lu, Haitao Zh |
| Racial and Sex Differences in Genomic Profiling of Intrahepatic Cholangiocarcinoma. Annals of surgical oncology 2024 9 . Diamantis I Tsilimigras, Hunter Stecko, Ioannis Ntanasis-Stathopoulos, Timothy M Pawl |
| Aberrant HIF1- ? and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations. Cancer control : journal of the Moffitt Cancer Center 2024 8 31 10732748241271714. Tariq Ali, Rohma Usman, Syed Alasar Shah, Aamir Parvez, Summayya Anwar, Zahid Muneer, Muhammad Sae |
| Comprehensive exploration on the role of base excision repair genes in modulating immune infiltration in low-grade glioma. Pathology, research and practice 2024 8 262 155559. Parthipan P, Subhadra Kumari, Santosh Kumar, Srinivasan Muthuswa |
| Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT. Bone marrow transplantation 2024 8 . Razan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, Jordi Esteve, Nicolaus Kröger, Jan J Cornelissen, Didier Blaise, Gerard Socié, Sébastien Maury, Arnold Ganser, Tobias Gedde-Dahl, Peter von dem Borne, Jean Henri Bourhis, Claude Eric Bulabois, Ibrahim Yakoub-Agha, Caroline Pabst, Stéphanie Nguyen, Patrice Chevallier, Anne Huynh, Ali Bazarbachi, Arnon Nagler, Fabio Ciceri, Mohamad Moh |
| Clonal Hematopoiesis-Associated Gene Mutations Affect Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation in AML Patients. Annals of transplantation 2024 7 29 e943688. Xiaoxuan Wei, Sai Huang, Zhenyang Gu, Jing Liu, Meng Li, Xiangshu Jin, Jian Bo, Fei Li, Yu Jing, Xiaoning Gao, Liping Dou, Daihong Liu, Chunji G |
| Raman Spectroscopy of Blood Serum for Essential Thrombocythemia Diagnosis: Correlation with Genetic Mutations and Optimization of Laser Wavelengths. Cell biochemistry and biophysics 2024 6 . Aynur Aday, Ay?e Gül Bayrak, Suat Toraman, ?pek Yönal Hindilerden, Meliha Nalçac?, Joanna Depciuch, Jozef Cebulski, Zozan Gulek |
| Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study. Blood science (Baltimore, Md.) 2024 6 6 (3): e00196. Mingyuan Sun, Qingsong Yin, Yang Liang, Chunkang Chang, Jing Zheng, Jian Li, Chunyan Ji, Huiying Qiu, Junmin Li, Yuping Gong, Sheng Luo, Yan Zhang, Rumei Chen, Zhenwei Shen, Zenglian Yue, Siyuan Wang, Qingmei Shi, Jason Yang, Jie Jin, Jianxiang Wa |
| Rapid Tumor DNA Analysis of Cerebrospinal Fluid Accelerates Treatment of Central Nervous System Lymphoma. Blood 2024 5 . Mihir Gupta, Joseph Bradley, Elie Massaad, Evan Burns, N Zeke Georgantas, Garrett Maron, Julie Batten, Aidan Gallagher, Julia Thierauf, Naema Nayyar, Amanda Gordon, SooAe Jones, Michelle Pisapia, Ying Sun, Pamela Stuart Jones, Fred G Barker, William Curry, Rajiv Gupta, Javier Romero, Nancy Wang, Priscilla Brastianos, Maria Martinez-Lage, Kensuke Tateishi, Deborah Anne Forst, Brian Vala Nahed, Tracy T Batchelor, Lauren L Ritterhouse, Florian Iser, Tobias Kessler, Justin T Jordan, Jorg Dietrich, Matthew L Meyerson, Daniel P Cahill, Jochen K Lennerz, Bob Carter, Ganesh M Shank |
| Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. British journal of cancer 2024 5 . Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Andrea Casadei-Gardini, David Tougeron, Jean-Marc Gornet, Marine Jary, Eric Terrebonne, Guillaume Piessen, Pauline Afchain, Cédric Lecaille, Marc Pocard, Thierry Lecomte, Margherita Rimini, Frédéric Di Fiore, Valérie Le Brun Ly, Stefano Cascinu, Dewi Vernerey, Pierre Laurent Pu |
| A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related. International journal of laboratory hematology 2024 4 . Dong Chen, Julia Geyer, Adam Bagg, Robert Hasserjian, Olga K Weinbe |
| Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data. Journal of neuro-oncology 2024 4 . Takanari Okamoto, Ryo Mizuta, Yoshinobu Takahashi, Yoshihiro Otani, Eiichi Sasaki, Yoshitsugu Horio, Hiroaki Kuroda, Hirokazu Matsushita, Isao Date, Naoya Hashimoto, Katsuhiro Masa |
| Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 2024 4 8 e2300407. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
| Longitudinal glioma monitoring via cerebrospinal fluid cell-free DNA. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 12 . Cecile Riviere-Cazaux, Xiaoxi Dong, Wei Mo, Rahul Kumar, Chao Dai, Lucas P Carlstrom, Amanda Munoz-Casabella, Keyvan Ghadimi, Cody L Nesvick, Katherine M Andersen, Matthew D Hoplin, Nicholas Canaday, Ignacio Jusue-Torres, Noor Malik, Jian L Campian, Michael W Ruff, Joon H Uhm, Jeanette E Eckel-Passow, Timothy J Kaufmann, David M Routman, Sani H Kizilbash, Ugur Sener, Arthur E Warrington, Robert B Jenkins, Pan Du, Shidong Jia, Terry C Bur |
| Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia. Bone marrow transplantation 2024 11 . Gege Gui, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery J Auletta, Firas El Chaer, Evan C Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil G Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Wael Saber, Stephen R Spellman, Scott L Zeger, Kristin M Page, Laura W Dillon, Christopher S Hourig |
| The Validation of Digital PCR-Based Minimal Residual Disease Detection for the Common Mutations in IDH1 and IDH2 Genes in Patients with Acute Myeloid Leukemia. The Journal of molecular diagnostics : JMD 2024 11 . Jing Di, Tao Sheng, Ranjana Aurora, Jennifer Stocks-Candelaria, Sainan Wei, Charles Lutz, Fevzi F Yalniz, Shulin Zha |
| Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ. Journal of neuro-oncology 2024 10 . Jordina Rincon-Torroella, Maureen Rakovec, Anita L Kalluri, Kelly Jiang, Carly Weber-Levine, Megan Parker, Divyaansh Raj, Josh Materi, Sadra Sepehri, Abel Ferres, Karisa C Schreck, Iban Aldecoa, Calixto-Hope G Lucas, Haris I Sair, Kristin J Redmond, Matthias Holdhoff, Jon Weingart, Henry Brem, Josep J González Sánchez, Xiaobu Ye, Chetan Bettegow |
| Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia. Nature genetics 2024 10 . Andrew Stiff, Maarten Fornerod, Bailee N Kain, Deedra Nicolet, Benjamin J Kelly, Katherine E Miller, Krzysztof Mrózek, Isaiah Boateng, Audrey Bollas, Elizabeth A R Garfinkle, Omolegho Momoh, Foluke A Fasola, Hannah O Olawumi, Nuria Mencia-Trinchant, Jean F Kloppers, Anne-Cecilia van Marle, Eileen Hu, Saranga Wijeratne, Gregory Wheeler, Christopher J Walker, Jill Buss, Adrienne Heyrosa, Helee Desai, Andrea Laganson, Ethan Hamp, Yazan Abu-Shihab, Hasan Abaza, Parker Kronen, Sidharth Sen, Megan E Johnstone, Kate Quinn, Ben Wronowski, Erin Hertlein, Linde A Miles, Alice S Mims, Christopher C Oakes, James S Blachly, Karilyn T Larkin, Bethany Mundy-Bosse, Andrew J Carroll, Bayard L Powell, Jonathan E Kolitz, Richard M Stone, Cassandra Duarte, Diana Abbott, Maria L Amaya, Craig T Jordan, Geoffrey L Uy, Wendy Stock, Kellie J Archer, Electra D Paskett, Monica L Guzman, Ross L Levine, Kamal Menghrajani, Debyani Chakravarty, Michael F Berger, Daniel Bottomly, Shannon K McWeeney, Jeffrey W Tyner, John C Byrd, Nathan Salomonis, H Leighton Grimes, Elaine R Mardis, Ann-Kathrin Eisfe |
| Characteristics and Prognosis of "Acute Promyelocytic Leukemia-like" Nucleophosmin-1-Mutated Acute Myeloid Leukemia in a Retrospective Patient Cohort. Biomedicines 2024 10 12 (10): . Vasiliki Papadopoulou, Giulia Schiavini, Gregoire Stalder, Valentin Basset, Jacqueline Schoumans, Mitja Nabergoj, Muriel Schall |
| [PET/CT with 11C-methionine as a predictor of disease-free survival in patients with IDH1 wild type diffuse glioma]. Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 2024 10 88 (5): 6-13. T Yu Skvortsova, Zh I Savintseva, A F Gurchin, R Yu Seliverst |
| GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
| Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with NPM1-mutated AML. HemaSphere 2025 1 9 (1): e70060. Sibylle Cocciardi, Maral Saadati, Nina Weiß, Daniela Späth, Silke Kapp-Schwoerer, Isabelle Schneider, Annika Meid, Verena I Gaidzik, Sabrina Skambraks, Walter Fiedler, Michael W M Kühn, Ulrich Germing, Karin T Mayer, Michael Lübbert, Elli Papaemmanuil, Felicitas Thol, Michael Heuser, Arnold Ganser, Lars Bullinger, Axel Benner, Hartmut Döhner, Konstanze Döhn |
- Page last reviewed:Feb 1, 2024
- Content source: